CanDiag, Inc.
CanDiag is pursuing development and commercialization of a blood test to accurately detect cancer and reduce unnecessary breast biopsies.
- Stage Concept Only
- Industry Biotechnology
- Location Charlotte, NC, USA
- Currency USD
- Website candiaginc.com
Company Summary
CanDiag, Inc., a UNC Charlotte spin-out, has developed a patented antibody based blood test to diagnose breast cancer. In a study involving women with suspicious mammograms, CanDiag's test identified invasive breast cancer with 100% sensitivity. Our mission is to initially offer diagnostics for breast cancer. Our vision is to offer products ranging from accurate cancer screening and imaging tests to targeted drug delivery therapies.
Team
-
Pinku MukherjeeCEO, Co-Founder
-
Rahul PuriCo-Founder, Director
-
Taffy WilliamsDirector
-
Myla Lai-GoldmanScientific Advisor
-
Susan AlpertRegulatory Consultant
-
Herbert Kim LyerlyScientific Advisor
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.